- FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims ( )
- FTC Issues Study on Competition in Contact Lens Market ( )
- FTC Charges Marketers with Making Deceptive Efficacy and Safety Claims about Ephedra and Yohimbine Dietary Supplements ( )
- Appeals Court Upholds FTC Ruling; Doan's Must Include Corrective Message in Future Advertising and Labeling ( )
- "Operation Cure.all" Nets Shark Cartilage Promoters: Two Companies Charged with Making False And Unsubstantiated Claims for Their Shark Cartilage And Skin Cream as Cancer Treatments ( )
- Doan's Pills Must Run Corrective Advertising: FTC Ads Claiming Doan's Is Superior In Treating Back Pain Were Unsubstantiated ( )
- Multi-Level Marketing Company to Settle FTC Charges That It Made Unsubstantiated Claims That Its "God's Recipe" Dietary Regimen Could Cure ADD/ADHD ( )
- Judge Upholds FTC Charges: Doan's Claims of Superiority in Treating Back Pain are Unsubstantiated ( )
- Announced Actions for September 12, 1997 ( )
- FTC Puts Exercise Device Weight-Loss Claims on a Diet ( )
- Court Order Brings to a Close FTC Lawsuit Against Makers of "Helsinki Formula" for its Baldness Cure Claims ( )
- Eggland's Best Cholesterol Claims Called Deceptive ( )